Clinical trial
Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
NCT00004846 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00004846 |
|---|---|
| Title | Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV |
| Official title | Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis C, HIV Infection |
| Intervention type | Drug |
| Interventions | ABC/Gen-Probe/Chiron HIV-1/HCV 001 |
| Enrollment | 30,000 |
| Start date | Dec 1, 1999 |
| Completion | Oct 1, 2002 |
| First posted | Mar 3, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: